The value of BioCentury, now inside the AI you use every day
BioCentury AI Connectors put our industry-leading analysis directly into your AI workflow, updated daily with our latest reports and content dating back to January 1, 2021. It’s the trusted insight you already rely on, now just a prompt away.
Supported Platforms
ChatGPT | Claude
More AI offerings are coming soon.
In drug development, good decisions can be game changing, and the cost of bad ones, gigantic
BioCentury AI Connectors help you map your strategy more confidently by allowing you to harness our trusted insights on the most important breakthroughs, deal activity, and industry shifts by way of conversational prompts within the world's leading AI platforms.
Explore example prompts
I am thinking of investing in a U.K. start-up. What does BioCentury say about the U.K. environment for life sciences companies, how is that ecosystem shaping up, and who are the key drivers I should be keeping an eye on?
Based on BioCentury coverage, what [emerging scientific platforms, novel targets, or early-pipeline trends] in [Therapeutic Area] have gained attention in the past 12 to 18 months but don't yet have approved drugs or late-stage programs?
In a table, summarize for [Therapeutic Area] the companies involved, the underlying science or mechanism, and any early signals — such as venture investment, academic activity, or early clinical entry — that BioCentury has identified as indicators of growing momentum.
Using BioCentury content and a web search, create a company brief on [Company Name] covering: pipeline summary by stage and indication, recent clinical data readouts, partnership or financing activity in the past two years, and any key risks or concerns raised in BioCentury's editorial coverage.
Based on BioCentury coverage, how has the FDA approached [Disease / Drug Class / Regulatory Topic, e.g., accelerated approval reforms] recently? Summarize key decisions and their implications.
These Connectors tap into your subscription with the power of AI and maintain the level of trust you expect from BioCentury
Whether you’re working in Claude or ChatGPT, the Connectors bring BioCentury’s proprietary analysis directly into your conversation, without a new login or a new tab.
Stay ahead of the game
Preparing for a board meeting, scoping therapeutic areas, or stress testing a deal thesis is now as simple as striking up a conversation with the BioCentury AI Connectors. You'll go from conventional search methods to surfacing critical insights and information through prompts at near instant speed.
Reach an informed position faster
The AI Connectors bring BioCentury’s editorial judgment and analyst expertise directly into your workflow on demand. Get briefing-quality answers sourced from human-led insights, without switching tools or losing context.
AI you can trust for high-stakes decisions
Where general AI tools draw on public, unverified information, BioCentury AI Connectors source directly from our proprietary, expert analysis, channeling well-vetted perspectives from our network of industry thought leaders. “I found this in BioCentury” carries real weight. Now so do answers your AI assistant surfaces.
Works inside the tools your team already uses
BioCentury Connectors are available in Claude and ChatGPT with more AI offerings coming soon.
More BioCentury AI products and features are on the way
BioCentury AI Connectors are the first step in a broader set of AI-powered tools being built in our intelligence platform
Over the coming months, you’ll be able to incorporate those capabilities into your workflows, whether you are seeking the latest science, analyzing deals, looking for investment, or monitoring the emerging competition.
BioCentury subscribers will get exclusive early access. Stay ahead of what’s coming and become a subscriber today.